Ophthalmology and Diabetic Retinopathy
Bcn Peptides S.A. is engaged in clinical research focused on non-proliferative diabetic retinopathy, with attention to microaneurysm burden and retinal disease progression in patients with moderate to severe forms of the condition.
- Non-proliferative diabetic retinopathy
- Microaneurysm reduction
- Retinal disease management
The sponsor’s work in this area reflects a therapeutic interest in topical ophthalmic treatments for preserving retinal health.
Healthy Volunteer Research
The company also supports clinical investigation in healthy volunteers, with emphasis on early human assessment of topical peptide-based candidates and their pharmacokinetics, safety, and tolerability.
- Pharmacokinetics
- Safety evaluation
- Tolerability assessment
This area indicates interest in establishing the clinical profile of new ophthalmic peptide therapies before use in patient populations.
Topical Peptide Therapeutics
Research activity includes development of topically administered peptide-based interventions designed for ocular use, with a focus on formulations intended to act directly at the eye surface and anterior ocular tissues.
- Topical ocular administration
- Peptide-based formulations
- Anterior eye treatment
The sponsor’s therapeutic interest centers on eye-directed drug development within a pharmaceutical research setting.
